Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells

International Journal of Biochemistry and Cell Biology

Volumn 44, Issue 2, 2012, Pages 341-349

  Veltman, Katharina ^a   Hummel, Stephanie ^a   Cichon, Christoph ^a   Sonnenborn, Ulrich ^b   Schmidt, Marcus Alexander ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Ardeypharm GmbH   (Germany)

Author keywords

Apical junctional complexes; E. coli Nissle 1917; Enteropathogenic E. coli; Epithelial barrier; Intestinal bowel disease; miRNA

Indexed keywords

MICRORNA; MICRORNA 203; MICRORNA 483 3P; MICRORNA 595; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CELL JUNCTION; ENTEROPATHOGENIC ESCHERICHIA COLI; EPITHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IC 50; NONHUMAN; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; SIMULATION; TIGHT JUNCTION; UPREGULATION; WESTERN BLOTTING;

CELL MEMBRANE; EPITHELIAL CELLS; ESCHERICHIA COLI; INTERCELLULAR JUNCTIONS; INTESTINES; MEMBRANE PROTEINS; MICRORNAS; PROBIOTICS; TIGHT JUNCTIONS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI NISSLE 1917;

EID: 84855567672     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2011.11.006     Document Type: Article

References (67)

1. A. Altenhoefer, S. Oswald, U. Sonnenborn, C. Enders, J. Schulze, and J. Hacker The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens FEMS Immunol Med Microbiol 40 3 2004 223 229 (Pubitemid 38368186)
2. S. Anand, B.K. Majeti, L.M. Acevedo, E.A. Murphy, R. Mukthavaram, and L. Scheppke MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis Nat Med 16 8 2010 909 914
3. R.K. Appleyard Segregation of new lysogenic types during growth of a doubly lysogenic strain derived from Escherichia coli K-12 Genetics 39 4 1954 440 452
4. I. Behm-Ansmant, J. Rehwinkel, T. Doerks, A. Stark, P. Bork, and E. Izaurralde mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes Genes Dev 20 14 2006 1885 1898 (Pubitemid 44079326)
5. J. Berkes, V.K. Viswanathan, S.D. Savkovic, and G. Hecht Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation Gut 52 3 2003 439 451 (Pubitemid 36253638)
6. M.J. Blaser, and S. Falkow What are the consequences of the disappearing human microbiota? Nat Rev Microbiol 7 12 2009 887 894
7. J. Boudeau, A.L. Glasser, S. Julien, J.F. Colombel, and A. Darfeuille-Michaud Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E coli strains isolated from patients with Crohn's disease Aliment Pharmacol Ther 18 1 2003 45 56 (Pubitemid 36897980)
8. M. Bruewer, S. Samarin, and A. Nusrat Inflammatory bowel disease and the apical junctional complex Ann N Y Acad Sci 1072 2006 242 252 (Pubitemid 44448457)
9. R.W. Carthew, and E.J. Sontheimer Origins mechanisms of miRNAs and siRNAs Cell 136 4 2009 642 655
10. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 10 2009 704 714
11. M.A. Croxen, and B.B. Finlay Molecular mechanisms of Escherichia coli pathogenicity Nat Rev Microbiol 8 1 2010 26 38
12. S.R. Dalal, and J.H. Kwon The role of microRNA in inflammatory bowel disease Gastroenterol Hepatol 6 11 2010 714 722
13. C. Dale, and N.A. Moran Molecular interactions between bacterial symbionts and their hosts Cell 126 3 2006 453 465 (Pubitemid 44163611)
14. D. Damaskos, and G. Kolios Probiotics and prebiotics in inflammatory bowel disease: microflora on the scope Br J Clin Pharmacol 65 4 2008 453 467 (Pubitemid 351365144)
15. M.E. Davis, J.E. Zuckerman, C.H. Choi, D. Seligson, A. Tolcher, and C.A. Alabi Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles Nature 464 7291 2010 1067 1070
16. P. Dean, and B. Kenny Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein Mol Microbiol 54 November (3) 2004 665 675 (Pubitemid 39457289)
17. M.F. Denning Tightening the epidermal barrier with atypical PKCs J Invest Dermatol 127 4 2007 742 744 (Pubitemid 46434670)
18. B.A. Duerkop, S. Vaishnava, and L.V. Hooper Immune responses to the microbiota at the intestinal mucosal surface Immunity 31 3 2009 368 376
19. A. Eulalio, E. Huntzinger, and E. Izaurralde Getting to the root of miRNA-mediated gene silencing Cell 132 1 2008 9 14
20. FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint WHO/FAO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. http://www.who.int/foodsafety/publications/fs-management/ probiotics2/en/, 2002.
21. A. Fasano, and J.P. Nataro Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins Adv Drug Deliv Rev 56 6 2004 795 807 (Pubitemid 38520100)
22. C. Forster Tight junctions and the modulation of barrier function in disease Histochem Cell Biol 130 1 2008 55 70
23. J.M. Friedman, and P.A. Jones MicroRNAs: critical mediators of differentiation, development and disease Swiss Med Wkly 139 33-34 2009 466 472
24. L. Gao, and I.G. Macara Isoforms of the polarity protein par6 have distinct functions J Biol Chem 279 40 2004 41557 41562 (Pubitemid 39313597)
25. L. Grozdanov, C. Raasch, J. Schulze, U. Sonnenborn, G. Gottschalk, and J. Hacker Analysis of the genome structure of the nonpathogenic probiotic Escherichia coli strain Nissle 1917 J Bacteriol 186 16 2004 5432 5441 (Pubitemid 39038145)
26. F. Gunzer, I. Hennig-Pauka, K.H. Waldmann, R. Sandhoff, H.J. Grone, and H.H. Kreipe Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli Am J Clin Pathol 118 3 2002 364 375 (Pubitemid 37046334)
27. I. Helfrich, A. Schmitz, P. Zigrino, C. Michels, I. Haase, and A. le Bivic Role of aPKC isoforms and their binding partners Par3 and Par6 in epidermal barrier formation J Invest Dermatol 127 4 2007 782 791 (Pubitemid 46434649)
28. N.A. Hering, and J.D. Schulzke Therapeutic options to modulate barrier defects in inflammatory bowel disease Dig Dis 27 4 2009 450 454
29. L.V. Hooper, M.H. Wong, A. Thelin, L. Hansson, P.G. Falk, and J.I. Gordon Molecular analysis of commensal host-microbial relationships in the intestine Science 291 5505 2001 881 884 (Pubitemid 32120760)
30. D.T. Humphreys, B.J. Westman, D.I. Martin, and T. Preiss MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function Proc Natl Acad Sci U S A 102 47 2005 16961 16966 (Pubitemid 41692666)
31. J. Karczewski, F.J. Troost, I. Konings, J. Dekker, M. Kleerebezem, and R.J. Brummer Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier Am J Physiol Gastrointest Liver Physiol 298 6 2010 G851 G859
32. W.P. Kloosterman, and R.H. Plasterk The diverse functions of microRNAs in animal development and disease Dev Cell 11 October (4) 2006 441 450 (Pubitemid 44430905)
33. E. Knust, and O. Bossinger Composition and formation of intercellular junctions in epithelial cells Science 298 5600 2002 1955 1959 (Pubitemid 35425244)
34. A. Krek, D. Grun, M.N. Poy, R. Wolf, L. Rosenberg, and E.J. Epstein Combinatorial microRNA target predictions Nat Genet 37 5 2005 495 500 (Pubitemid 40617277)
35. W. Kruis, P. Fric, J. Pokrotnieks, M. Lukas, B. Fixa, and M. Kascak Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Gut 53 11 2004 1617 1623 (Pubitemid 39434105)
36. W. Kruis, E. Schutz, P. Fric, B. Fixa, G. Judmaier, and M. Stolte Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis Aliment Pharmacol Ther 11 5 1997 853 858
37. R.E. Lanford, E.S. Hildebrandt-Eriksen, A. Petri, R. Persson, M. Lindow, and M.E. Munk Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection Science 327 5962 2010 198 201
38. S. Lebeer, J. Vanderleyden, and S.C. De Keersmaecker Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens Nat Rev Microbiol 8 3 2010 171 184
39. M.M. Levine, E.J. Bergquist, D.R. Nalin, D.H. Waterman, R.B. Hornick, and C.R. Young Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive Lancet 1 8074 1978 1119 1122 (Pubitemid 8356436)
40. B.P. Lewis, C.B. Burge, and D.P. Bartel Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 1 2005 15 20 (Pubitemid 40094598)
41. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 December (7) 2003 787 798 (Pubitemid 38058492)
42. M. Li, C. Marin-Muller, U. Bharadwaj, K.H. Chow, Q. Yao, and C. Chen MicroRNAs: control and loss of control in human physiology and disease World J Surg 33 4 2009 667 684
43. R. Lodinova-Zadnikova, and U. Sonnenborn Effect of preventive administration of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants Biol Neonat 71 4 1997 224 232 (Pubitemid 27153776)
44. L.F. Lu, and A. Liston MicroRNA in the immune system, microRNA as an immune system Immunology 127 3 2009 291 298
45. V.J. McCracken, and R.G. Lorenz The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota Cell Microbiol 3 1 2001 1 11 (Pubitemid 32107421)
46. L.B. McKenna, J. Schug, A. Vourekas, J.B. McKenna, N.C. Bramswig, and J.R. Friedman MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function Gastroenterology 139 5 2010 1654 1664 [1664.e1]
47. A.S. Neish Microbes in gastrointestinal health and disease Gastroenterology 136 1 2009 65 80
48. C.D. Packey, and R.B. Sartor Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases Curr Opin Infect Dis 22 3 2009 292 301
49. C. Pagnini, R. Saeed, G. Bamias, K.O. Arseneau, T.T. Pizarro, and F. Cominelli Probiotics promote gut health through stimulation of epithelial innate immunity Proc Natl Acad Sci U S A 107 1 2010 454 459
50. S.I. Patzer, M.R. Baquero, D. Bravo, F. Moreno, and K. Hantke The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN Microbiology 149 Pt 9 2003 2557 2570 (Pubitemid 37160730)
51. B.J. Rembacken, A.M. Snelling, P.M. Hawkey, D.M. Chalmers, and A.T. Axon Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial Lancet 354 9179 1999 635 639 (Pubitemid 29391428)
52. R. Rempe, S. Cramer, S. Huwel, and H.J. Galla Transport of poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity Biochem Biophys Res Commun 406 1 2011 64 69
53. S.C. Resta-Lenert, and K.E. Barrett Modulation of intestinal barrier properties by probiotics: role in reversing colitis Ann N Y Acad Sci 1165 May 2009 175 182
54. A. Rodriguez, E. Vigorito, S. Clare, M.V. Warren, P. Couttet, and D.R. Soond Requirement of bic/microRNA-155 for normal immune function Science 316 5824 2007 608 611 (Pubitemid 46683148)
55. R.B. Sartor Microbial influences in inflammatory bowel diseases Gastroenterology 134 2 2008 577 594 (Pubitemid 351173057)
56. M. Schultz Clinical use of E. coli Nissle 1917 in inflammatory bowel disease Inflamm Bowel Dis 14 7 2008 1012 1018
57. P.M. Sherman, J.C. Ossa, and K. Johnson-Henry Unraveling mechanisms of action of probiotics Nutr Clin Pract 24 1 2009 10 14
58. E. Sonkoly, and A. Pivarcsi Advances in microRNAs: implications for immunity and inflammatory diseases J Cell Mol Med 13 1 2009 24 38
59. W. Strober, I. Fuss, and P. Mannon The fundamental basis of inflammatory bowel disease J Clin Invest 117 3 2007 514 521 (Pubitemid 46348505)
60. R. Thermann, and M.W. Hentze Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation Nature 447 7146 2007 875 878 (Pubitemid 46920140)
61. S.N. Ukena, A. Singh, U. Dringenberg, R. Engelhardt, U. Seidler, and W. Hansen Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity PLoS One 2 12 2007 e1308
62. J. Wehkamp, J. Harder, K. Wehkamp, B. Wehkamp-von Meissner, M. Schlee, and C. Enders NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium Infect Immun 72 10 2004 5750 5758 (Pubitemid 39303685)
63. A.M. Westendorf, F. Gunzer, S. Deppenmeier, D. Tapadar, J.K. Hunger, and M.A. Schmidt Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules FEMS Immunol Med Microbiol 43 3 2005 373 384 (Pubitemid 40228949)
64. F. Wu, M. Zikusoka, A. Trindade, T. Dassopoulos, M.L. Harris, and T.M. Bayless MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha Gastroenterology 135 5 2008 1624 1635 e1624
65. F. Yan, and D.B. Polk Commensal bacteria in the gut: learning who our friends are Curr Opin Gastroenterol 20 6 2004 565 571 (Pubitemid 39447166)
66. Q. Zhou, W.W. Souba, C.M. Croce, and G.N. Verne MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome Gut 59 6 2010 775 784
67. A.A. Zyrek, C. Cichon, S. Helms, C. Enders, U. Sonnenborn, and M.A. Schmidt Molecular mechanisms underlying the probiotic effects of Escherichia coli Nissle 1917 involve ZO-2 and PKCzeta redistribution resulting in tight junction and epithelial barrier repair Cell Microbiol 9 3 2007 804 816 (Pubitemid 46231983)